# Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis

> **NCT00547053** · PHASE1 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Amiloride Solution for Inhalation

## Key facts

- **NCT ID:** NCT00547053
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-01
- **Final completion:** 2011-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2011-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547053, "Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00547053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*